<unk>  is an interleukin-6 (IL-6) receptor antagonist that is FDA approved for the treatment of rheumatoid arthritis (RA), polyarticular juvenile idiopathic arthritis (PJIA), systemic juvenile idiopathic arthritis (SJIA). There is a Black Box Warning for this drug as shown here.  Common adverse reactions include upper respiratory tract infections, nasopharyngitis, headache, hypertension, increased ALT, injection site reactions.
Tocilizumab
Bococizumab
Ixekizumab
Caplacizumab
Atezolizumab
Reslizumab
Risankizumab
Ravulizumab